A THYMUS-DEPENDENT SERUM FACTOR INDUCES MATURATION OF THYMOCYTES AS EVALUATED BY GRAFT-VERSUS-HOST REACTIONASTALDI GCB; ASTALDI A; WIJERMANS P et al.1980; CELL. IMMUNOL.; USA; DA. 1980; VOL. 49; NO 1; PP. 202-207; BIBL. 18 REF.Article

LOW BETA -ADRENERGIC RECEPTOR CONCENTRATION ON HUMAN THYMOCYTESVAN DE GRIEND RJ; ASTALDI A; WIJERMANS P et al.1983; CLINICAL AND EXPERIMENTAL IMMUNOLOGY; ISSN 0009-9104; GBR; DA. 1983; VOL. 51; NO 1; PP. 53-60; BIBL. 23 REF.Article

THYMOSIN-INDUCED HUMAN SERUM FACTOR INCREASING CYCLIC AMP.ASTALDI A; ASTALDI GCB; WIJERMANS P et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 1106-1108; BIBL. 16 REF.Article

A turbidimetric micro test for the diagnosis of hereditary spherocytosisVERWEIJ, W; IMANDT, L; WIJERMANS, P et al.Clinical and laboratory haematology. 1986, Vol 8, Num 3, pp 261-264, issn 0141-9854Article

SERUM THYMIC FACTOR IN SUBACUTE SCLEROSING PANENCEPHALITIS PATIENTSWIJERMANS P; ASTALDI A; ASTALDI GCB et al.1979; CLIN. IMMUNOL. IMMUNOPATHOL.; USA; DA. 1979; VOL. 12; NO 1; PP. 105-110; BIBL. 31 REF.Article

A THYMUS-DEPENDENT HUMAN SERUM FACTOR INDUCES A DECREASE OF TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE IN THYMOCYTESASTALDI GCB; ASTALDI A; WIJERMANS P et al.1979; IMMUNOL. LETT.; ISSN 0165-2478; NLD; DA. 1979; VOL. 1; NO 3; PP. 155-159; BIBL. 23 REF.Article

CHANGES IN HUMAN T LYMPHOCYTES AFTER THYMECTOMY AND DURING SENESCENCEVAN DE GRIEND RJ; CARRENO M; VAN DOORN R et al.1982; JOURNAL OF CLINICAL IMMUNOLOGY; ISSN 0271-9142; USA; DA. 1982; VOL. 2; NO 4; PP. 289-295; BIBL. 44 REF.Article

Successful chemotherapy for acute myeloid leucaemia in HIV-infected patientsWIJERMANS, P. W; TEN KATE, R. W.European journal of haematology. 1990, Vol 44, Num 2, pp 136-138, issn 0902-4441Article

Severe immunodeficiency in patients treated with fludarabine monophosphateWIJERMANS, P. W; GERRITS, W. B. J; HAAK, H. L et al.European journal of haematology. 1993, Vol 50, Num 5, pp 292-296, issn 0902-4441Article

Disappearance of a mucosa-associated lymphoid tissue (MALT) lymphoma of the urinary bladder after treatment for Helicobacter pyloriVAN DEN BOSCH, J; KROPMAN, R. F; BLOK, P et al.European journal of haematology. 2002, Vol 68, Num 3, pp 187-188, issn 0902-4441Article

Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphomaKRULDER, J. W. M; BRIMICOMBE, R. W; WIJERMANS, P. W et al.Mycoses. 1996, Vol 39, Num 3-4, pp 121-123, issn 0933-7407Article

Mitoxantrone, teniposide, chlorambucil and prednisone (MVLP) for relapsed non-Hodgkin's lymphoma : the impact of advanced age of performance statusHAAK, H. L; GERRITS, W. B. J; WIJERMANS, P. W et al.Netherlands journal of medicine. 1993, Vol 42, Num 3-4, pp 122-127, issn 0300-2977Conference Paper

Interferon-α in treatment of intraepithelilal neoplasia of the lower genital tract: a case reportSLOTMAN, B. J; HELMERHORST, T. J. M; WIJERMANS, P. W et al.European journal of obstetrics, gynecology, and reproductive biology. 1988, Vol 27, Num 4, pp 327-333, issn 0301-2115Article

Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphomaYPMA, P. F; WIJERMANS, P. W; KOPPEN, H et al.Netherlands journal of medicine. 2006, Vol 64, Num 7, pp 243-247, issn 0300-2977, 5 p.Article

Continuous infusion of low-dose 5-Aza-2'-deoxycytidine in elderly patients with high-risk myelodysplastic syndromeWIJERMANS, P; KRULDER, J. W. M; HUIJGENS, P. C et al.Leukemia. 1997, Vol 11, Num 1, pp 1-5, issn 0887-6924Article

Presenting signs and symptoms in multiple myeloma : high percentages of stage III among patients without apparent myeloma-associated symptomsONG, F; HERMANS, J; NOORDIJK, E. M et al.Annals of hematology (Print). 1995, Vol 70, Num 3, pp 149-152, issn 0939-5555Article

Kaposi's sarcoma in an HIV-negative CLL patient as the cause of thrombocytopeniaWIJERMANS, P. W; VAN GRONINGEN, K; VAN ROYEN, E. A et al.Annals of hematology (Print). 1994, Vol 68, Num 6, pp 307-310, issn 0939-5555Article

Changes in the expression of N-acetylglucosaminyltransferase III, IV, V associated with the differentiation of HL-60 cellsKOENDERMAN, A. H. L; WIJERMANS, P. W; VAN DEN EIJNDEN, D. H et al.FEBS letters. 1987, Vol 222, Num 1, pp 42-46, issn 0014-5793Article

The spectrum of chronic mature T-cell disorders : a report of four casesBROUWER, R. E; KOK, S. W; VAN DEIJK, W. A et al.Netherlands journal of medicine. 1996, Vol 48, Num 4, pp 133-139, issn 0300-2977Conference Paper

Hyaline-vascular type Castleman's disease with concomitant malignant B-cell lymphomaBUIJS, L; WIJERMANS, P. W; VAN GRONINGEN, K et al.Acta haematologica. 1992, Vol 87, Num 3, pp 160-162, issn 0001-5792Article

Purification of human megakaryocytes using a glycoprotein Ib dependent agglutination techniqueVAN PAMPUS, E. C. M; HUIJGENS, P. C; WIJERMANS, P. W et al.Clinical and laboratory haematology. 1990, Vol 12, Num 3, pp 301-307, issn 0141-9854, 7 p.Article

Maturation induction in freshly isolated human myeloid leukemic cells, 1.25(OH)₂ vitamin D3 being the most potent inducerOSSENKOPPELE, G. J; WIJERMANS, P. W; NAUTA, J. J. P et al.Leukemia research. 1989, Vol 13, Num 7, pp 609-614, issn 0145-2126Article

Serum neural cell adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causesONG, F; KAISER, U; SEELEN, P. J et al.Blood. 1996, Vol 87, Num 2, pp 712-716, issn 0006-4971Article

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the NetherlandsLAROS-VAN GORKOM, B. A. P; HUISMAN, C. A. M; WIJERMANS, P. W et al.Netherlands journal of medicine. 2007, Vol 65, Num 9, pp 333-338, issn 0300-2977, 6 p.Article

Combined procoagulant activity and proteolytic activity of acute promyelocytic leukemic cells: reversal of the bleeding disorder by cell differentiationWIJERMANS, P. W; REBEL, V. I; OSSENKOPPELE, G. J et al.Blood. 1989, Vol 73, Num 3, pp 800-805, issn 0006-4971Article